Cargando…

The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience

In early March 2020, the University of Washington Medical Center clinical virology laboratory became one of the first clinical laboratories to offer testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). When we first began test development in mid-January, neither of us believed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Greninger, Alexander L., Jerome, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383557/
https://www.ncbi.nlm.nih.gov/pubmed/32703897
http://dx.doi.org/10.1128/JCM.01416-20
_version_ 1783563442544705536
author Greninger, Alexander L.
Jerome, Keith R.
author_facet Greninger, Alexander L.
Jerome, Keith R.
author_sort Greninger, Alexander L.
collection PubMed
description In early March 2020, the University of Washington Medical Center clinical virology laboratory became one of the first clinical laboratories to offer testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). When we first began test development in mid-January, neither of us believed there would be more than 2 million confirmed SARS-CoV-2 infections nationwide or that we would have performed more than 150,000 real-time PCR (RT-PCR) tests, with many more to come. This article will be a chronological summary of how we rapidly validated tests for SARS-CoV-2, increased our testing capacity, and addressed the many problems that came up along the way.
format Online
Article
Text
id pubmed-7383557
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-73835572020-07-31 The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience Greninger, Alexander L. Jerome, Keith R. J Clin Microbiol Commentary In early March 2020, the University of Washington Medical Center clinical virology laboratory became one of the first clinical laboratories to offer testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). When we first began test development in mid-January, neither of us believed there would be more than 2 million confirmed SARS-CoV-2 infections nationwide or that we would have performed more than 150,000 real-time PCR (RT-PCR) tests, with many more to come. This article will be a chronological summary of how we rapidly validated tests for SARS-CoV-2, increased our testing capacity, and addressed the many problems that came up along the way. American Society for Microbiology 2020-07-23 /pmc/articles/PMC7383557/ /pubmed/32703897 http://dx.doi.org/10.1128/JCM.01416-20 Text en Copyright © 2020 American Society for Microbiology. All Rights Reserved (https://doi.org/10.1128/ASMCopyrightv2) . https://doi.org/10.1128/ASMCopyrightv2 This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Commentary
Greninger, Alexander L.
Jerome, Keith R.
The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
title The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
title_full The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
title_fullStr The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
title_full_unstemmed The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
title_short The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
title_sort first quarter of sars-cov-2 testing: the university of washington medicine experience
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383557/
https://www.ncbi.nlm.nih.gov/pubmed/32703897
http://dx.doi.org/10.1128/JCM.01416-20
work_keys_str_mv AT greningeralexanderl thefirstquarterofsarscov2testingtheuniversityofwashingtonmedicineexperience
AT jeromekeithr thefirstquarterofsarscov2testingtheuniversityofwashingtonmedicineexperience
AT greningeralexanderl firstquarterofsarscov2testingtheuniversityofwashingtonmedicineexperience
AT jeromekeithr firstquarterofsarscov2testingtheuniversityofwashingtonmedicineexperience